10-K: HealthLynked Corp. Reports Fiscal Year 2023 Results, Cites Going Concern Uncertainty
Annual Results
HealthLynked Corp.'s 2023 annual report reveals a net loss of $1 million, a significant improvement from the previous year, but also raises concerns about the company's ability to continue as a going concern.
Summary
- HealthLynked Corp. reported a net loss of $1,012,203 for the fiscal year ended December 31, 2023, a substantial decrease from the $8,815,744 loss in 2022.
- The company's revenue totaled $5,722,379, a slight decrease of 2% compared to $5,858,202 in the previous year.
- Patient service revenue saw a minor increase of 1%, reaching $5,484,278, while subscription and event revenue surged by 183% to $58,901.
- Product revenue experienced a significant drop of 58%, falling to $179,200.
- Operating expenses decreased by 32% to $9,874,090, primarily due to cost-cutting measures and lower impairment losses.
- The company recognized a gain of $2,674,069 from the sale of its ACO/MSO division.
- A gain of $1,090,857 was realized from contingent sale consideration related to the sale of AHP.
- The company's cash balance as of December 31, 2023, was $247,222, with a working capital deficit of $1,755,864 and an accumulated deficit of $42,033,136.
- Management has expressed substantial doubt about the company's ability to continue as a going concern without additional funding.
Sentiment
Score: 4
Explanation: The document presents a mixed picture. While there are positive signs of improved financial performance and growth in certain areas, the going concern warning and low cash balance raise significant concerns about the company's future viability. The overall sentiment is cautiously negative.
Positives
- The company's net loss decreased significantly, indicating improved financial performance.
- Subscription and event revenue saw substantial growth, suggesting increased adoption of the HealthLynked Network.
- The sale of the ACO/MSO division resulted in a significant gain, improving the company's financial position.
- Cost-cutting measures led to a substantial reduction in operating expenses.
- The company realized a gain from contingent sale consideration, further boosting its financial results.
Negatives
- The company's product revenue declined significantly, indicating challenges in the medical distribution division.
- The company has a substantial working capital deficit and accumulated deficit.
- Management has expressed substantial doubt about the company's ability to continue as a going concern without additional funding.
- The company's cash balance is low, raising concerns about its short-term liquidity.
Risks
- The company's current cash and cash equivalents may not be sufficient to fund operations for the next twelve months.
- The company's ability to continue as a going concern is dependent on securing additional financing.
- The company has identified material weaknesses in its internal control over financial reporting.
- The company's sales strategy may not be successful, impacting the growth of the HealthLynked and MOD businesses.
- The company relies on a sole supplier for product sales through MOD, creating a supply chain risk.
- The healthcare industry is highly regulated, and the company may face challenges in complying with applicable laws.
- The company relies on Amazon Web Services, and any disruption could negatively affect operations.
- The market for internet-based medical information systems may not develop as expected.
- The company may be unable to adequately protect its intellectual property.
- The company may be subject to medical malpractice and other lawsuits not covered by insurance.
Future Outlook
Management believes that current cash resources and opportunities will be insufficient to execute the business plan for twelve months after the date these financial statements are issued and that securing substantial additional sources of financing is possible, but there is no assurance of the company's ability to secure such financing.
Management Comments
- Management believes that available cash and cash equivalents will not be sufficient to fund operations for the next twelve months without generating positive cash flows and raising additional capital.
- Management has expressed substantial doubt about the company's ability to continue as a going concern without additional funding.
- Management plans to raise additional capital to fund ongoing operations and invest in the digital healthcare business.
Industry Context
The company operates in the competitive digital healthcare and medical distribution industries, facing established competitors with greater resources. The company is attempting to differentiate itself through its unified healthcare network and small unit-of-measure distribution model.
Comparison to Industry Standards
- HealthLynked's revenue growth is below that of some competitors in the digital health space, such as Teladoc Health Inc., which has seen significant growth in recent years.
- The company's reliance on a single supplier for its medical distribution business is a risk not typically seen in larger, more diversified distributors like McKesson Corp. and Medline.
- The company's net loss, while improved, is still significant compared to more established players in the healthcare technology sector, such as AthenaHealth Inc. and Allscripts Healthcare Solutions, Inc.
- The company's cash position and going concern warning are concerning compared to industry benchmarks, where companies typically have more robust financial stability.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Financial Officer | George OLeary | David Rosal | April 4, 2024 | Resignation of George OLeary |
Related Party Transactions
- The company has entered into various notes payable agreements with Dr. Michael Dent and trusts controlled by him.
- The company has paid consulting fees to Dr. Dent's spouse.
- The company has issued stock awards to its outside directors.
Stakeholder Impact
- Shareholders face significant risk due to the company's going concern warning and potential dilution from future capital raises.
- Employees may be concerned about the company's financial stability and potential job security.
- Customers may be affected by potential disruptions in service or product availability.
- Suppliers may face increased risk of non-payment or delayed payments.
- Creditors face increased risk of default on outstanding debt.
Next Steps
- The company plans to continue investing in its digital healthcare business, including the HealthLynked Network.
- The company intends to market the HealthLynked Network to large health systems, hospitals, and universities.
- The company plans to leverage its medical distribution business to grow the HealthLynked Network.
- The company intends to hire telesales representatives to increase market penetration.
Key Dates
| Date | Description |
|---|---|
| August 6, 2014 | HealthLynked Corp. was incorporated in the state of Nevada. |
| May 13, 2022 | HealthLynked Corp. acquired Aesthetic Enhancements Unlimited (AEU). |
| January 17, 2023 | HealthLynked Corp. entered into an agreement to sell its ACO/MSO division. |
| December 31, 2023 | End of the fiscal year for which financial results are reported. |
| April 1, 2024 | Date of the report and employee count. |
Keywords
HealthLynked, financial results, going concern, healthcare technology, digital health, medical distribution, revenue, net loss, operating expenses, impairment, ACO, MSO, MedOffice Direct, HealthLynked Network, internal control, risk factors
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.